From: Risk factors of sleep paralysis in a population of Polish students
Group SP+/SP-: | Â | SP + | SP - | p |
---|---|---|---|---|
N | Â | 846 | 1707 | Â |
% Female (n) | Â | 32.2 (656) | 67.8 (1382) | 0.04a |
% Male (n) | Â | 36.9 (190) | 63.1 (325) | |
Age | M (SD) | 22 (2.38) | 21 (2.20) | Â |
Me | 22.0 | 21.0 | ||
RNG | 18–35 | 18–35 | <0.001a | |
Psychiatric disorder % (n) | Anxiety | 2.7% (23) | 1.2% (20) | 0.006a |
Mood | 4.1% (35) | 2.2% (37) | 0.004a | |
Others | – | 0.5% (9) |  | |
Somatic disease % (n) | Endocrine | 7.3% (62) | 6.3% (107) | 0.13 |
Allergic and Atopic | 4.5% (38) | 5.2% (88) | 0.5 | |
Autoimmune | 3.7% (31) | 3.3% (57) | 0.62 | |
Pulmonary | 3.3% (28) | 2.7% (46) | 0.44 | |
Gastrointestinal | 2.6% (22) | 1.2% (21) | 0.01a | |
Cardiovascular | 1.9% (16) | 1% (17) | 0.09 | |
Neurological | 1.8% (15) | 1.3% (22) | 0.3 | |
Hematologic | 1.2% (10) | 0.5% (9) | 0.05 | |
One health problem % (n) | Â | 20.3% (172) | 17.6% (300) | 0.09 |
Two health problem % (n) | Â | 5.2% (44) | 4.5% (76) | 0.4 |
Three or more health problem % (n) | Â | 3.4% (29) | 1.5% (26) | 0.003a |
Medicines taken % (n) | Antidepressants | 6.3% (53) | 2.5% (43) | 0.02a |
Mood stabilizers | 0.9% (8) | 0.7% (12) | 0.41 | |
Thyroid hormones | 6.1% (52) | 5.9% (100) | 0.77 | |
Hormonal contraception | 5.3% (45) | 3.6% (62) | 0.50 | |
Antiallergic and anti-asthmatic | 3.9% (33) | 4.5% (76) | 0.51 |